Computed Tomography (CT) Market Size, Share, Growth, and Industry Analysis, By Type (Oncology,Cardiology,Musculoskeletal Disorders,Gastrointestinal Diseases), By Application (Diagnostic Centers,Hospitals & Clinics), Regional Insights and Forecast to 2035

Computed Tomography (CT) Market Overview

The global Computed Tomography (CT) Market is forecast to expand from USD 5333.55 million in 2026 to USD 5527.69 million in 2027, and is expected to reach USD 7355.52 million by 2035, growing at a CAGR of 3.64% over the forecast period.

The computed tomography (CT) market processed more than 98 million scans globally in 2024, with hospitals accounting for 71% of usage and diagnostic centers handling the remaining 29%. Multi-slice CT systems represented 64% of installed equipment, enabling faster imaging and reduced radiation doses. Technological advancements, such as spectral CT and AI-assisted image reconstruction, have penetrated over 43% of high-end CT installations worldwide. The Computed Tomography (CT) Market Market Report highlights that over 15,000 new CT units were installed globally in 2024, with Asia-Pacific leading in volume additions and North America maintaining leadership in advanced clinical applications.

The USA performed over 92 CT scans per 1,000 population in 2024, equating to more than 30.5 million scans annually. There are approximately 13,800 operational CT units in the country, with 58% installed in hospitals and 42% in outpatient or diagnostic centers. Oncology represents 29% of U.S. CT scan usage, followed by cardiology at 22%. The Computed Tomography (CT) Market Market Analysis shows the USA leads globally in low-dose CT adoption, with 41% of scanners meeting latest dose-reduction compliance standards. California, Texas, and New York collectively operate over 2,900 CT units, accounting for 21% of national capacity.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 68% demand growth linked to early disease detection initiatives and preventive screening programs.
• Major Market Restraint: 44% cost impact from high acquisition and maintenance expenses.
• Emerging Trends: 52% increase in AI-enabled CT imaging deployments.
• Regional Leadership: Asia-Pacific holds 39% of unit installations, North America 31%, Europe 23%, others 7%.
• Competitive Landscape: Top 5 manufacturers control 62% of global CT system sales.
• Market Segmentation: Hospitals & clinics comprise 71% of usage, diagnostic centers 29%.
• Recent Development: 37% surge in spectral CT system installations between 2023–2025.

Computed Tomography (CT) Market Latest Trends

The Computed Tomography (CT) Market Market Trends indicate a clear shift toward multi-slice, low-dose, and AI-assisted imaging. Multi-slice systems accounted for 64% of the 2024 installed base, with 128-slice and above configurations growing by 19% year-on-year. AI integration in CT reporting has reduced image interpretation times by up to 27%, with adoption increasing by 52% since 2021. The demand for spectral CT systems surged, reaching over 4,200 installations globally, largely in oncology and cardiology specialties. Low-dose lung cancer screening programs, active in over 42 countries, drove 11.3 million dedicated CT scans in 2024. Portable and mobile CT units, now making up 7% of the global market, saw deployment in over 1,200 rural healthcare facilities. The Computed Tomography (CT) Market Market Growth is also supported by an increase in hybrid imaging technologies, with PET/CT and SPECT/CT scanners comprising 14% of high-end diagnostic equipment purchases in 2024.

Computed Tomography (CT) Market Dynamics

DRIVER

"Rising demand for early and accurate diagnostics"

Over 98 million CT scans performed globally in 2024 reflect growing adoption for early detection of cancer, cardiovascular conditions, and trauma-related injuries. National screening programs in the U.S., Japan, and the UK contributed to a 68% increase in preventive CT scans over the last five years. The Computed Tomography (CT) Market Industry Analysis confirms that early diagnosis reduces treatment costs by up to 35%, incentivizing healthcare systems to expand CT access.

RESTRAINT

"High equipment and maintenance costs"

Acquisition costs for high-end CT systems range from $1 million to $2.5 million per unit, while annual maintenance expenses can exceed $150,000. This results in a 44% cost barrier for smaller facilities and emerging market hospitals. The Computed Tomography (CT) Market Market Forecast notes that even with financing options, repayment periods extend beyond 7 years for premium systems in low-volume centers.

OPPORTUNITY

"AI-assisted imaging and workflow automation"

AI-enabled CT imaging solutions have grown 52% since 2021, with clinical trials showing interpretation accuracy improvements of up to 16% for complex cases. Automated reconstruction algorithms now reduce scan times by 30%, allowing for 25% higher patient throughput. The Computed Tomography (CT) Market Market Opportunities highlight that over 8,000 AI-enhanced CT units are expected to be deployed in hospitals by 2027.

CHALLENGE

"Radiation dose management and patient safety"

Despite advances, only 41% of CT scanners worldwide are equipped with the latest dose-reduction protocols. Regulatory pressures in the EU and U.S. have mandated tighter controls, increasing compliance-related operational costs by 18%. The Computed Tomography (CT) Market Market Insights emphasize that improving patient safety without compromising image quality remains a technological challenge.

Computed Tomography (CT) Market Segmentation

The Computed Tomography (CT) Market Market Size is divided into clinical types and end-user applications. Oncology accounted for 29% of CT procedures in 2024 with over 28 million scans, cardiology 21% with more than 8 million CT angiography cases, musculoskeletal disorders 18% with 17.6 million scans, and gastrointestinal diseases 14% with 13.7 million abdominal exams. Hospitals and clinics performed 71% of total scans, exceeding 69.6 million, while diagnostic centers handled 29%, completing 28.4 million procedures. Together, these segments highlight the Computed Tomography (CT) Market Market Growth driven by diversified clinical applications and strong demand from hospital-based imaging.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Oncology: Oncology-related scans accounted for 29% of all CT procedures in 2024, equal to over 28 million scans worldwide. Multi-phase contrast imaging is used in 71% of these cases for tumor staging and treatment monitoring.

Oncology CT applications are expected to reach USD 2,061.88 million in 2025, representing 40.1% of the global CT market, with a CAGR of 3.7% to 2034, driven by rising cancer screening and precision imaging adoption worldwide.

Top 5 Major Dominant Countries in the Oncology Segment

• United States: USD 824.75 million in 2025, 40.0% share, 3.6% CAGR, supported by over 1.9 million annual cancer diagnoses and 5,500+ oncology-specialized imaging centers.
• China: USD 618.56 million in 2025, 30.0% share, 3.8% CAGR, fueled by expanding cancer screening programs covering over 150 million people annually.
• Japan: USD 206.19 million in 2025, 10.0% share, 3.5% CAGR, sustained by an aging population and nationwide cancer screening initiatives.
• Germany: USD 185.57 million in 2025, 9.0% share, 3.6% CAGR, with 2,200+ diagnostic radiology departments offering oncology CT services.
• India: USD 144.33 million in 2025, 7.0% share, 3.9% CAGR, driven by rapid expansion of cancer care centers in tier-2 and tier-3 cities.

Cardiology: Cardiac CT scans made up 21% of total usage in 2024, with coronary artery calcium scoring representing 44% of these cases. More than 8 million patients underwent CT angiography for cardiovascular risk assessment.

Cardiology CT applications are projected at USD 1,030.06 million in 2025, holding a 20.0% market share, with a CAGR of 3.6% to 2034, supported by non-invasive heart imaging adoption for cardiovascular risk assessment.

Top 5 Major Dominant Countries in the Cardiology Segment

• United States: USD 412.02 million in 2025, 40.0% share, 3.5% CAGR, with over 500,000 cardiac CT scans performed annually.
• China: USD 309.02 million in 2025, 30.0% share, 3.7% CAGR, benefiting from increasing coronary artery disease screening.
• Japan: USD 103.01 million in 2025, 10.0% share, 3.6% CAGR, focused on early detection of heart disease in aging demographics.
• Germany: USD 92.71 million in 2025, 9.0% share, 3.5% CAGR, integrating cardiac CT into preventive care frameworks.
• India: USD 72.10 million in 2025, 7.0% share, 3.9% CAGR, supported by rising heart disease prevalence and urban healthcare expansion.

Musculoskeletal Disorders: MSK-related CT usage accounted for 18% of procedures in 2024, primarily for trauma imaging, fracture diagnosis, and orthopedic planning. Around 17.6 million MSK CT scans were performed globally.

Musculoskeletal disorder CT scans are valued at USD 874.86 million in 2025, making up 17.0% of the market, with a CAGR of 3.5% to 2034, driven by trauma, sports injury diagnostics, and orthopedic imaging demand.

Top 5 Major Dominant Countries in the Musculoskeletal Disorders Segment

• United States: USD 314.95 million in 2025, 36.0% share, 3.4% CAGR, led by 8.6 million annual sports injury cases requiring advanced imaging.
• China: USD 262.46 million in 2025, 30.0% share, 3.6% CAGR, driven by urban accident and fracture treatment needs.
• Japan: USD 87.49 million in 2025, 10.0% share, 3.5% CAGR, with demand from elderly fall-related injuries.
• Germany: USD 78.74 million in 2025, 9.0% share, 3.5% CAGR, providing CT diagnostics in 1,500+ orthopedic clinics.
• India: USD 61.24 million in 2025, 7.0% share, 3.8% CAGR, with expanding trauma care infrastructure in major cities.

Gastrointestinal Diseases: GI-focused CT scans represented 14% of global usage, with CT colonography and abdominal imaging leading demand. Approximately 13.7 million abdominal CT scans were conducted worldwide in 2024.

Gastrointestinal CT applications are estimated at USD 1,179.42 million in 2025, accounting for 23.0% of the global market, with a CAGR of 3.7% to 2034, driven by GI cancer detection and inflammatory bowel disease diagnostics.

Top 5 Major Dominant Countries in the Gastrointestinal Diseases Segment

• United States: USD 448.98 million in 2025, 38.0% share, 3.6% CAGR, performing over 3 million abdominal CT scans annually.
• China: USD 353.83 million in 2025, 30.0% share, 3.8% CAGR, with growing GI disorder detection programs.
• Japan: USD 117.94 million in 2025, 10.0% share, 3.5% CAGR, supported by high gastric cancer screening rates.
• Germany: USD 106.15 million in 2025, 9.0% share, 3.6% CAGR, with strong integration into preventive diagnostics.
• India: USD 82.56 million in 2025, 7.0% share, 3.9% CAGR, benefiting from wider CT accessibility in public hospitals.

BY APPLICATION

Diagnostic Centers: Diagnostic centers handled 29% of global CT procedures in 2024, performing more than 28.4 million scans. These facilities cater to outpatient services and account for 37% of elective imaging.

Diagnostic centers are expected to hold USD 3,092.18 million in 2025, representing 60.1% of the CT market, with a CAGR of 3.6% to 2034, driven by outpatient imaging demand and specialized scanning services.

Top 5 Major Dominant Countries in Diagnostic Centers

• United States: USD 1,237.00 million in 2025, 40.0% share, 3.5% CAGR, with over 6,000 accredited diagnostic imaging facilities.
• China: USD 927.65 million in 2025, 30.0% share, 3.7% CAGR, expanding community-based imaging networks.
• Japan: USD 309.22 million in 2025, 10.0% share, 3.6% CAGR, providing advanced CT in private diagnostics.
• Germany: USD 278.29 million in 2025, 9.0% share, 3.5% CAGR, integrating CT into independent radiology groups.
• India: USD 216.45 million in 2025, 7.0% share, 3.8% CAGR, with rapid private diagnostic center growth.

Hospitals & Clinics: Hospitals and clinics conducted 71% of CT procedures, totaling over 69.6 million scans in 2024. Emergency departments alone contributed 22% of hospital CT scans.

Hospitals & clinics will account for USD 2,054.04 million in 2025, making up 39.9% share, with a CAGR of 3.7% to 2034, sustained by inpatient diagnostic needs and emergency care imaging.

Top 5 Major Dominant Countries in Hospitals & Clinics

• United States: USD 802.08 million in 2025, 39.0% share, 3.6% CAGR, with CT scanners installed in over 95% of hospitals.
• China: USD 616.21 million in 2025, 30.0% share, 3.8% CAGR, with CT use in major tertiary hospitals.
• Japan: USD 205.40 million in 2025, 10.0% share, 3.5% CAGR, ensuring CT in emergency care settings.
• Germany: USD 184.86 million in 2025, 9.0% share, 3.6% CAGR, serving surgical and trauma departments.
• India: USD 143.78 million in 2025, 7.0% share, 3.9% CAGR, with government investment in hospital diagnostic infrastructure.

Computed Tomography (CT) Market Regional Outlook

Asia-Pacific 39%, North America 31%, Europe 23%, Middle East & Africa 7%. Asia-Pacific led with 39% of CT scan volume in 2024, performing over 38.2 million scans, driven by China’s 41% regional share and Japan’s world-leading 111 scans per 1,000 population. North America held 31% share with more than 31 million scans, dominated by the U.S. at 96% of regional procedures, while Europe captured 23% share with 22.5 million scans, led by Germany, France, and the UK. The Middle East & Africa accounted for 7% share, conducting 6.8 million scans, with GCC countries contributing 54% and South Africa leading African adoption.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America performed over 31 million CT scans in 2024, with the U.S. accounting for 96% of regional procedures. Hospitals operated 58% of CT units, while outpatient centers ran 42%. Canada saw a 12% increase in CT scan volume due to expanded public healthcare coverage.

North America is projected at USD 1,905.10 million in 2025, 37.0% share, with a CAGR of 3.6% to 2034, supported by advanced healthcare infrastructure and high imaging procedure volumes.

North America - Major Dominant Countries

• United States: USD 1,544.00 million, 81.0% share, 3.6% CAGR, leading in CT scan adoption with over 90 million scans annually.
• Canada: USD 228.61 million, 12.0% share, 3.5% CAGR, supported by national imaging programs.
• Mexico: USD 76.20 million, 4.0% share, 3.7% CAGR, expanding CT capacity in private hospitals.
• Cuba: USD 38.26 million, 2.0% share, 3.5% CAGR, upgrading imaging in tertiary care hospitals.
• Panama: USD 18.03 million, 1.0% share, 3.6% CAGR, investing in urban diagnostic centers.

EUROPE

Europe completed over 22.5 million CT scans in 2024, with Germany (18%), France (16%), and the UK (15%) leading demand. Low-dose CT adoption reached 48% across the EU, with screening programs in oncology driving usage.

Europe will be USD 1,441.97 million in 2025, representing 28.0% share, with a CAGR of 3.5% to 2034, driven by universal healthcare coverage and expanding preventive imaging.

Europe - Major Dominant Countries

• Germany: USD 403.75 million, 28.0% share, 3.5% CAGR, with strong diagnostic infrastructure.
• France: USD 331.65 million, 23.0% share, 3.4% CAGR, providing CT under national insurance schemes.
• UK: USD 288.39 million, 20.0% share, 3.5% CAGR, enhancing NHS imaging capacity.
• Italy: USD 230.71 million, 16.0% share, 3.5% CAGR, supporting cancer and cardiac diagnostics.
• Spain: USD 187.47 million, 13.0% share, 3.6% CAGR, with growing radiology demand.

ASIA-PACIFIC

Asia-Pacific handled more than 38.2 million CT scans in 2024, with China alone contributing 41% of regional volume. Japan’s per capita CT scan rate is the world’s highest at 111 per 1,000 population.

Asia is estimated at USD 1,544.00 million in 2025, 30.0% share, with a CAGR of 3.7% to 2034, fueled by large patient populations and increasing healthcare investment.

Asia - Major Dominant Countries

• China: USD 772.00 million, 50.0% share, 3.8% CAGR, dominating in CT unit installations.
• Japan: USD 309.22 million, 20.0% share, 3.5% CAGR, with high per capita scan rates.
• India: USD 247.04 million, 16.0% share, 3.9% CAGR, expanding CT in public health programs.
• South Korea: USD 123.52 million, 8.0% share, 3.6% CAGR, investing in AI-assisted imaging.
• Indonesia: USD 92.64 million, 6.0% share, 3.8% CAGR, upgrading provincial hospitals.

MIDDLE EAST & AFRICA

MEA performed 6.8 million CT scans in 2024, with the Gulf Cooperation Council (GCC) countries accounting for 54% of usage. South Africa remains the largest African market with over 1.2 million scans annually.

Middle East & Africa will total USD 255.15 million in 2025, 5.0% share, with a CAGR of 3.5% to 2034, supported by expanding urban hospitals and imaging centers.

Middle East & Africa - Major Dominant Countries

• UAE: USD 76.54 million, 30.0% share, 3.6% CAGR, investing in AI-integrated CT.
• Saudi Arabia: USD 66.34 million, 26.0% share, 3.5% CAGR, expanding tertiary hospitals.
• South Africa: USD 51.03 million, 20.0% share, 3.5% CAGR, upgrading regional medical centers.
• Egypt: USD 33.17 million, 13.0% share, 3.4% CAGR, increasing CT access in state hospitals.
• Qatar: USD 28.07 million, 11.0% share, 3.5% CAGR, enhancing private diagnostic services.

List of Top Computed Tomography (CT) Companies

• MARS Bioimaging Ltd (Christchurch, New Zealand)
• General Electric Company (US)
• Koninklijke Philips N.V. (Amsterdam, Netherlands)
• Siemens (UK)
• Neusoft Corporation (China)
• Shenzhen Anke High-tech Co., Ltd (China)
• PerkinElmer Inc. (Waltham, Massachusetts)

Top 2 by Market Share:

1. Siemens – Over 5,200 units installed globally, 18% market share.
2. General Electric Company – 4,900 units installed, 17% market share.

Investment Analysis and Opportunities

Between 2023 and 2025, over $6.5 billion was invested in CT system production and upgrades, with Asia-Pacific capturing 43% of this funding. North America allocated $2.1 billion to low-dose CT expansion, while Europe invested in 640 new spectral CT units.

New Product Development

From 2023–2025, over 120 new CT models were introduced, 38% with AI integration. Siemens launched photon-counting CT with 30% higher spatial resolution, while GE debuted a portable CT weighing under 800 kg for field hospitals.

Five Recent Developments

• Siemens installed its 1,000th photon-counting CT unit globally in 2024.
• GE Healthcare expanded CT production capacity in Wisconsin by 25%.
• Philips launched AI-based cardiac CT analysis software in 2023.
• Neusoft introduced a 512-slice CT scanner for high-throughput hospitals.
• MARS Bioimaging completed clinical trials for spectral molecular imaging CT.

Report Coverage

The Computed Tomography (CT) Market Market Report covers clinical usage, equipment types, technological advances, and regional trends. It includes analysis of over 98 million scans in 2024, unit installation data, and competitive benchmarking.

Computed Tomography (CT) Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 5333.55 Million in 2026
Market Size Value By	USD 7355.52 Million by 2035
Growth Rate	CAGR of 3.64% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Oncology Cardiology Musculoskeletal Disorders Gastrointestinal Diseases By Application : Diagnostic Centers Hospitals & Clinics
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample